# About Meds Wolverine: An Independent BPC-157 TB-500 Research Digest

> About Meds Wolverine — an independent editorial project that logs the published BPC-157 TB-500 research record. Not a clinic, not a pharmacy, not a vendor.

An independent editorial project that reads the BPC-157 TB-500 research record as two logged constituents — and says plainly where the evidence stops.

## What this publication is

Meds Wolverine is an independent editorial project that publishes summaries of the peer-reviewed research literature on BPC-157 TB-500 — the two-peptide "Wolverine" blend. We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "meds" in the name describes our subject, not our services. It marks an interest in what the blend is studied *for* and in how regulatory and compounding access actually works — the questions a medicinally-minded reader brings — and nothing more. There is no dispensary here, no prescriber, and no storefront.

## How we read the record

We treat the blend the way a data console treats two records. BPC-157 and TB-500 are logged separately, each finding tagged to the constituent it belongs to and carrying a verification status: VERIFIED for a citation-confirmed single-compound result, PRECLINICAL for rodent-only or in-vitro work, EXTRAPOLATED for the theoretical synergy claim, and NO-HUMAN-DATA for the gaps the combination leaves open.

That discipline is the whole editorial stance. The blend's marketing implies a unity the chemistry does not support, so we keep the two records distinct, attribute every quantitative claim to a study, and flag the combination row as empty because no controlled trial has filled it. Where the human data belong to full-length Thymosin Beta-4 rather than the TB-500 fragment, we say so.

## What we do not do

We do not recommend doses, routes, or protocols for any person. We describe what was administered to which species at which dose by which route, and we stop there. We do not sell the blend or either constituent, and we link to no vendor. We do not offer consultation, treatment, or prescription services, and the editorial framing in our name is a position relative to the literature — not a claim about services we provide. Every page is sourced; the [full reference list](/references) is the spine of the site.

---

Two peptides logged as two records on one console — BPC-157 and TB-500 each weighed against its own studies and its 503A status, the combination row left reading NO-HUMAN-DATA, with no clinic behind the panel and nothing here dispensed.